Cardinal Health, Inc. (NYSE:CAH) Annual Evercore ISI HealthCONx Healthcare Conference December 3, 2024 1:30 PM ET
Company Participants
Matt Sims – VP, IR
Aaron Alt – CFO
Conference Call Participants
Elizabeth Anderson – Evercore ISI
Elizabeth Anderson
Hi, everybody. Thanks so much for joining us today. I’m Elizabeth Anderson. I’m Evercore’s Healthcare services analyst. I’m very pleased to be joined today by Aaron Alt, CFO of Cardinal Health; as well as Matt Sims, who’s going to read to us the disclosures.
Matt Sims
Well, great. Thanks for hosting us today, Elizabeth. It’s great to be here. Before we begin, let me remind that we will be making forward-looking statements today, which are subject to risks and uncertainties that could cause our actual results to differ materially from those projected or implied. For a description of these factors, please review our SEC filings, which can be found on our Investor Relations website at ir.cardinalhealth.com.
Question-and-Answer Session
Q – Elizabeth Anderson
All right. Awesome. Thanks so much for joining us. So maybe just to kick it off, one of the things that I think has held up very well this year as sort of core utilization, right? So if we think about sort of the drivers of the core pharma guide, how do we think about utilization and sort of the underlying trends within that across the different sort of drug categories?
Aaron Alt
Elizabeth, thank you for having us here today. We’re delighted to be here to talk about our business on behalf of our entire team and Jason, in particular. We were pleased recently to have a strong Q1 driven in no small part by the very utilization you referenced, and I’ll talk to some of the details in a second.
As a result of that Q1, we actually raised our
Read the full article here
